SQUIRE PATTON BOGGS for BRISTOL-MYERS SQUIBB COMPANY
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Prescription Drug Savings and Choice Act (S. 333/H.R. 684); Medicaid Prescription Drug Rebate Equalization Act of 2009 (HR 904); Drug Rebate Equalization Act of 2009 (S 547) Voluntary State Discount Prescription Drug Plan Act of 2009 (HR 1725)
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS HALE BOGGS | — |
| JOHN JONAS | — |
| MARTHA KENDRICK | — |
| KAREN THIEL | — |
| MATTHEW TODD TUTEN | — |
Health Issues HCR
American Recovery and Reinvestment Act (PL 111-5); Promoting Innovation and Access to Life-Saving Medicine Act (HR 1427/S 726); Pathway for Biosimilars Act (HR 1548); Patient-Centered Outcomes Research Act of 2009 (S1213); Comparative Effectiveness Research Act of 2009 (HR 2502); Doctor-Patient Relationship and Research Protection Act (HR 2824); Protecting Consumer Access to Generic Drugs Act of 2009 (HR 1706); Food and Drug Administration Globalization Act of 2009 (HR 759); Drug and Device Accountability Act of 2009 (S 882) Pharmaceutical Market Access and Drug Safety Act of 2009 (HR 1298/S 1232)
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS HALE BOGGS | — |
| JOHN JONAS | — |
| MARTHA KENDRICK | — |
| KAREN THIEL | — |
| MATTHEW TODD TUTEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.